期刊文献+

NDRG2基因启动子甲基化与肺腺癌细胞中mRNA表达相关性的实验研究 被引量:2

Promoter Methylation and Gene Expression of NDRG2 Gene in Lung Cancer Cells
下载PDF
导出
摘要 目的:探讨肺腺癌细胞中NDRG2基因启动子甲基化状态及其与基因表达的关系。方法:甲基化焦磷酸测序技术检测启动子区域甲基化状态,荧光定量PCR技术检测不同药物浓度下培养细胞中NDRG2基因mRNA的表达水平,分析启动子区域甲基化与基因表达之间的关系。结果:在体外培养细胞中检测到NDRG2基因启动子区域呈现不同程度的甲基化,甲基化频率分别为肺癌A549细胞71.8%、GLC-82细胞86.1%、人脐静脉内皮ECV-304细胞36.8%、胃上皮GES-1细胞42.9%。NDRG2基因mRNA表达与其启动子甲基化程度成反比,甲基转移酶抑制剂5-杂氮-2-脱氧胞苷(5-Aza-CdR)作用于细胞后,A549和GLC-82细胞中NDRG2基因的mRNA转录明显上调,至72 h差异显著(P<0.05)。结论:肺腺癌细胞中NDRG2基因启动子CpG岛存在高甲基化,甲基化程度与该基因的表达具有负相关性,5-Aza-CdR能在一定程度上提高NDRG2的转录水平。 Objective: To investigate the relationship between NDRG2 gene promoter methylation and gene expression in lung cancer cells.Methods: NDRG2 promoter methylation was detected by pyrosequencing,NDRG2 mRNA expression were quantified by real-time PCR.Culture cells demethylation were processed by 5-Aza-CdR treatment.Results: The methylation frequency of NDRG2 promoter in lung cancer cells A549 was 71.8% and in GLC-82 cells was 86.1%.In control cells,the methylation frequency was 36.8% in ECV-304 cells and 42.9% in GES-1 cells respectively.NDRG2 mRNA expression were up-regulated from 24 to 72 h after 5-Aza-CdR treatment(P 0.05) in A549 and GLC-82 cells.Conclusion: NDRG2 promoter methylation was detected in the four tested cells.The methylation frequency in lung cancer cells was higher than in control cells.The promoter methylation of NDRG2 was probably responsible for its transcription silence in lung cancer cells,and 5-Aza-CdR can restore the transcription of NDRG2.
出处 《生物技术通讯》 CAS 2010年第5期614-618,共5页 Letters in Biotechnology
基金 西安市科技发展引导基金[SF09027(2)]
关键词 NDRG2基因 启动子甲基化 焦磷酸测序 5-杂氮-2-脱氧胞苷 基因表达 NDRG2 gene promoter methylation pyrosequencing 5-Aza-CdR gene expression
  • 相关文献

参考文献2

二级参考文献14

  • 1张松法,叶枫,陈怀增,谢幸.基因组CpG岛甲基化检测技术研究进展[J].国际遗传学杂志,2006,29(3):201-203. 被引量:15
  • 2Fakhrai-Rad H,Pourmand N,Ronaghi M.Pyrosequencing:an accurate detection platform for single nucleotide polymorphisms[J].Hum Murat,2002,19(5):479-485.
  • 3Roupret M,Hupertan V,Catto JW,et al.Promoter hypermethylation in circulating blood cells identifies prostate cancer progression[J].Int J Cancer,2008,122(4):952-956.
  • 4Qin W,Zhu W,Shi H,et al.Soy isoflavones have an antiestragenic effect and alter mammary promoter hypermethylation in healthy premenopausal women[J].Nutr Cancer,2009,61 (2):238-244.
  • 5Ehrich M,Nelson MR,Stanssens P,et al.Quantitative highthroughput analysis of DNA methylation patterns by base-specifc cleavage and mass spectrometry[J].Proc Natl Aced Sci U S A,2005,102(44):15785-15790.
  • 6Fukasawa M,Kimura M,Morita S,et al.Microarray analysis of promoter methylation in lung cancers[J].J Hum Genet,2006,51(4):368-374.
  • 7Dupont JM,Tost J,Jammes H,et al.De novo quantitative bisulfite sequencing using the pyrosequencing technology[J].Anal Biochem,2004,333(1):119-127.
  • 8Liu MC,Choong DY,Hooi CS,et al.Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer[J].Cancer Lett,2007,247(1):91-97.
  • 9Leung WK,To KF,Chu ES,et al.Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer[J].Br J Cancer,2005,92 (12):2190-2194.
  • 10Shaw R J,Liloglou T,Rogers SN,et al.Promoter methylation of P16,RARbeta,E-cadherin,cyclin A1 and cytoglobin in oral cancer:quantitative evaluation using pyrosequencing[J].Br J Cancer,2006,94(4):561-568.

共引文献28

同被引文献16

  • 1Qu x, Zhai Y, Wei H, et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family [J]. Mol Cell Biochem, 2002, 229(1-2) : 35-44.
  • 2Liu N, Wang L, Liu X, et al. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression lev- els in several cancer cell lines [ J]. Biochem Biophys Res Commun, 2007, 358(1) : 164-169.
  • 3Tahara T, Arisawa T. Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation [ J]. Expert Rev Mol Diagn, 2012, 12(5) : 489-497.
  • 4Piepoli A, Cotugno R, Merla G, et al. Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour [J]. BMC Med Genomies, 2009, 2:11.
  • 5Lorentzen A, Vogel LK, Lewinsky RH, et al. Expression of NDRG2 is down-regulated in high-risk adenomas and eolorectal carcinoma [ J]. BMC Cancer, 2007, 7: 192.
  • 6Furuta H, Kondo Y, Nakahata S, et al. NDRG 2 is a candidate tumor- suppressor for oral sqaamous-cell carcinoma [ J]. Biochem Biophys Res Commun, 2010, 391(4) : 1785-1791.
  • 7Chang X, Li Z, Ma J, et al. DNA methylation of NDRG2 in gastric cancer and its clinical significance [ J]. Dig Dis Sci, 2013, 58 (3) : 715-723.
  • 8赵莹,孙丽华,杨振华,王锋.5-Aza-CdR对肺癌A549细胞DNA甲基转移酶活性的影响[J].南京医科大学学报(自然科学版),2009,29(6):767-770. 被引量:3
  • 9熊慧华,邱红,庄亮,熊华,姜蕊,陈元.Effects of 5-Aza-CdR on the Proliferation of Human Breast Cancer Cell Line MCF-7 and on the Expression of Apaf-1 Gene[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2009,29(4):498-502. 被引量:5
  • 10赵华栋,付强,张健,鲁建国,何显力,王青,南菁,杨媛,药立波.应用组织芯片技术研究抑癌候选基因NDRG2在甲状腺肿瘤组织中的表达及其意义[J].现代肿瘤医学,2010,18(3):453-455. 被引量:2

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部